Home › Epidermolysis Bullosa
Epidermolysis Bullosa clinical trials recruiting in the U.S.
6 studies for Epidermolysis Bullosa are recruiting participants at sites across the United States.
By state
Recently updated studies
Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa
RecruitingPhase 3
28 Days – 12 Years · All sexes · Updated Sep 4, 2026 · NCT07482787Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions
Recruiting
Ages 5 to 21 · All sexes · Updated Aug 24, 2026 · NCT07780981A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Aug 13, 2026 · NCT07027345A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
RecruitingPhase 2
Ages 4 and older · All sexes · Updated Aug 12, 2026 · NCT06594393Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
RecruitingPhase 1/2
Ages 6 and older · All sexes · Updated May 5, 2026 · NCT06834035Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
RecruitingEarly phase 1
6 Months · All sexes · Updated May 1, 2026 · NCT05649098From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.